Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,223,245 papers from all fields of science
Search
Sign In
Create Free Account
Temocapril
Known as:
(2S-(2alpha,6beta(R*)))-6-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic Acid
, Temocaprilum
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
temocapril hydrochloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Species difference of esterase expression and hydrolase activity in plasma.
F. Bahar
,
Kayoko Ohura
,
T. Ogihara
,
T. Imai
Journal of Pharmacy and Science
2012
Corpus ID: 21302549
Differences in esterase expression among human, rhesus monkey, cynomolgus monkey, dog, minipig, rabbit, rat, and mouse plasma…
Expand
Highly Cited
2006
Highly Cited
2006
Aldosterone breakthrough during therapy with angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy
Y. Horita
,
K. Taura
,
T. Taguchi
,
A. Furusu
,
S. Kohno
Nephrology
2006
Corpus ID: 31741078
Background: We are investigating whether aldosterone breakthrough negatively impacts on the antiproteinuric effects of…
Expand
Highly Cited
2004
Highly Cited
2004
Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
A. T. Zaman
,
S. Fujii
,
+7 authors
A. Kitabatake
Journal of Molecular and Cellular Cardiology
2004
Corpus ID: 22502037
Highly Cited
2003
Highly Cited
2003
Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension
M. Furuhashi
,
N. Ura
,
+5 authors
K. Shimamoto
HYPERTENSION
2003
Corpus ID: 8916087
Abstract—Adiponectin, an adipocyte-derived protein, has been suggested to play an important role in insulin sensitivity. We…
Expand
Highly Cited
2003
Highly Cited
2003
Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.
Yasuhiro Nakamura
,
M. Yoshiyama
,
+6 authors
J. Yoshikawa
Cardiovascular Research
2003
Corpus ID: 14668083
Highly Cited
2002
Highly Cited
2002
ACE Inhibitor Improves Insulin Resistance in Diabetic Mouse Via Bradykinin and NO
T. Shiuchi
,
T. Cui
,
+4 authors
M. Horiuchi
HYPERTENSION
2002
Corpus ID: 16834676
Improvement of insulin resistance by ACE inhibitors has been suggested; however, this mechanism has not been proved. We…
Expand
Highly Cited
2000
Highly Cited
2000
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
Y. Taniyama
,
R. Morishita
,
+7 authors
T. Ogihara
Circulation
2000
Corpus ID: 5609257
BACKGROUND Because hepatocyte growth factor (HGF) prevented and/or regressed fibrosis in liver and pulmonary injury models, HGF…
Expand
Highly Cited
2000
Highly Cited
2000
The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
K. Higashiura
,
N. Ura
,
+6 authors
K. Shimamoto
American Journal of Hypertension
2000
Corpus ID: 14904937
Highly Cited
1999
Highly Cited
1999
cDNA cloning, characterization and stable expression of novel human brain carboxylesterase
M. Mori
,
M. Hosokawa
,
Y. Ogasawara
,
Eiko Tsukada
,
K. Chiba
FEBS Letters
1999
Corpus ID: 5792413
Highly Cited
1997
Highly Cited
1997
Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension.
H. Iwatsubo
,
M. Nagano
,
+5 authors
T. Hata
HYPERTENSION
1997
Corpus ID: 69234
Endothelial function is known to be impaired in essential hypertensive patients. In this study, we examined whether…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE